1. Home
  2. ELTX vs WIMI Comparison

ELTX vs WIMI Comparison

Compare ELTX & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • WIMI
  • Stock Information
  • Founded
  • ELTX 2011
  • WIMI 2015
  • Country
  • ELTX United States
  • WIMI China
  • Employees
  • ELTX N/A
  • WIMI N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • WIMI Computer Software: Prepackaged Software
  • Sector
  • ELTX Health Care
  • WIMI Technology
  • Exchange
  • ELTX Nasdaq
  • WIMI Nasdaq
  • Market Cap
  • ELTX 49.7M
  • WIMI 97.0M
  • IPO Year
  • ELTX 2021
  • WIMI 2020
  • Fundamental
  • Price
  • ELTX $4.16
  • WIMI $0.88
  • Analyst Decision
  • ELTX Buy
  • WIMI
  • Analyst Count
  • ELTX 2
  • WIMI 0
  • Target Price
  • ELTX $10.00
  • WIMI N/A
  • AVG Volume (30 Days)
  • ELTX 16.1K
  • WIMI 408.8K
  • Earning Date
  • ELTX 11-07-2024
  • WIMI 01-01-0001
  • Dividend Yield
  • ELTX N/A
  • WIMI N/A
  • EPS Growth
  • ELTX N/A
  • WIMI N/A
  • EPS
  • ELTX N/A
  • WIMI N/A
  • Revenue
  • ELTX N/A
  • WIMI $84,137,968.00
  • Revenue This Year
  • ELTX N/A
  • WIMI N/A
  • Revenue Next Year
  • ELTX N/A
  • WIMI N/A
  • P/E Ratio
  • ELTX N/A
  • WIMI N/A
  • Revenue Growth
  • ELTX N/A
  • WIMI 19.25
  • 52 Week Low
  • ELTX $2.96
  • WIMI $0.56
  • 52 Week High
  • ELTX $11.45
  • WIMI $1.87
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 40.82
  • WIMI 47.40
  • Support Level
  • ELTX $4.05
  • WIMI $0.88
  • Resistance Level
  • ELTX $4.89
  • WIMI $0.90
  • Average True Range (ATR)
  • ELTX 0.28
  • WIMI 0.04
  • MACD
  • ELTX -0.06
  • WIMI -0.01
  • Stochastic Oscillator
  • ELTX 27.37
  • WIMI 26.76

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

Share on Social Networks: